日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Monoclonal humanized monovalent antibody blocking therapy for anti-NMDA receptor encephalitis.

用于治疗抗NMDA受体脑炎的单克隆人源化单价抗体阻断疗法

Kanno Atsuo, Kito Takuya, Maeda Masashi, Yamaki Shanni, Amano Yasushi, Shimomura Takuya, Anisimova Margarita, Kanazawa Naomi, Suzuki Koichiro, Razai Amir, Mihara Takuma, Kubo Kaori, Shimada Takeshi, Nakamura Koji, Nomura Naoko, Kondo Yuji, Okimoto Akira, Sugiyama Azusa, Park Deborah, Stein Ivar, Petshow Samuel, Vandendoren Valentin, Bilic Sanela, Kazimi Roghiye, Eastman Vallari, Snipas Scott J, Mitchell Mathew, Maurer Mari, Jefson Marty, Lichter Jay, Yamajuku Daisuke, Shirai Hiroki, Adachi Megumi, Hoeppner Daniel J, Kubo Satoshi, Zito Karen, Iizuka Takahiro, Flynn Peter, Matsumoto Mitsuyuki

Angiotensin II-induced cardiac hypertrophy and fibrosis are promoted in mice lacking Fgf16

在缺乏Fgf16的小鼠中,血管紧张素II诱导的心脏肥大和纤维化得到促进。

Matsumoto, Emi; Sasaki, Sayaka; Kinoshita, Hideyuki; Kito, Takuya; Ohta, Hiroya; Konishi, Morichika; Kuwahara, Koichiro; Nakao, Kazuwa; Itoh, Nobuyuki